Neogenomics Inc
NEO· Nasdaq
Filed Oct 25, 2011 · 10-Q · 25 days after period end · 0001193125-11-280085
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Net Income | -$143.00K | -$1.20M |
| EPS Diluted | $0.00 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Oct 25, 2011 · 25 d after period end